iANTHUS CAPITAL HOLDINGS (ITHUF) Income from Continuing Operations (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Income from Continuing Operations came in at 14309000.0 in Q1 2026, down 377.84% year-on-year from 5150000.0 in Q1 2025, and down 1.55% quarter-over-quarter from 14090000.0 in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Income from Continuing Operations (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 14309000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 14309000.0, down 377.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 59662000.0 (down 580.92% YoY), and the FY2025 annual result was 40203000.0, down 44.05% from the prior year.
  • Income from Continuing Operations came in at 14309000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from 14090000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 7519000.0 in Q4 2024 to a low of 373562000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 14309000.0 (2026), against an average of 35790235.29.
  • Across the five-year window, Income from Continuing Operations sank 2348.62% in 2022 and jumped 140.22% in 2024, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Income from Continuing Operations stood at 43732000.0 in 2022, then surged by 57.25% to 18695000.0 in 2023, then jumped by 140.22% to 7519000.0 in 2024, then slumped by 287.39% to 14090000.0 in 2025, then retreated by 1.55% to 14309000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 14309000.0 (Q1 2026), 14090000.0 (Q4 2025), and 12545000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn -14.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.31 Mn
Dec 31, 2025 -14.09 Mn
Sep 30, 2025 -12.55 Mn
Jun 30, 2025 -18.72 Mn
Mar 31, 2025 5.15 Mn
Dec 31, 2024 7.52 Mn
Sep 30, 2024 -11.64 Mn
Jun 30, 2024 -9.79 Mn
Mar 31, 2024 -14.00 Mn
Dec 31, 2023 -18.70 Mn
Sep 30, 2023 -19.18 Mn
Jun 30, 2023 -20.15 Mn
Mar 31, 2023 -18.60 Mn
Dec 31, 2022 -43.73 Mn
Sep 30, 2022 -22.00 Mn
Jun 30, 2022 -373.56 Mn
Mar 31, 2022 -10.10 Mn
Dec 31, 2021 -26.95 Mn
Sep 30, 2021 -15.84 Mn
Jun 30, 2021 -15.26 Mn